![](/img/cover-not-exists.png)
LT-171-861, a novel FLT3 inhibitor, shows excellent preclinical efficacy for the treatment of FLT3 mutant acute myeloid leukemia
Yu, Zhou, Du, Jiaying, Hui, Hui, Kan, Shaoxin, Huo, Tongxin, Zhao, Kai, Wu, Tao, Guo, Qinglong, Lu, NaVolume:
11
Year:
2021
Journal:
Theranostics
DOI:
10.7150/thno.46593
File:
PDF, 2.67 MB
2021